Public research preview
Byron Donalds, Representative disclosure: IDEXX Laboratories, Inc. - Common Stock (IDXX)
Disclosed a buy transaction in IDEXX Laboratories, Inc. - Common Stock (IDXX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 7 Oct 2025, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 33 days
Timeline
Transaction date
4 Sept 2025
Public disclosure
7 Oct 2025
Now
Tracked today
Filing delay: 33 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 12 Jun 2026
Stock path
IDXX from pre-transaction context through latest close.
Bought
4 Sept 2025 · 640,44 USD · Not public yet
System decision
Would not buy — The strategy's filters reject this signal. Failed filters: Filed within 30 days.
- Not public yet
- Would not buy
- Observed transaction close
- 640,44
- Observed disclosure close
- 627,28
- Observed latest close
- 553,845
- Pre-disclosure move
- -2.1%
- Post-disclosure move
- -11.7%
- Market-adjusted move
- -22.6%
- Pre-disclosure peak run-up
- +2.5%
- Retrace from peak
- -4.4%
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 7 Oct 2025, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%